{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Genomics in Chronic Lymphocytic Leukemia: Current Research & Future Implications

Purpose of Activity

To provide information on the use of genomics in the treatment and understanding of chronic lymphocytic leukemia (CLL).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Recognize various somatic mutations that work together to generate the CLL phenotype.
  2. Identify promising treatment strategies targeting specific genomic profiles for CLL.
Price: $12.95


  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: OT0218
Published: Feb 2018
Expires: 12/6/2019
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Brandon May